Palatin Technologies
This article was originally published in The Gray Sheet
Executive Summary
Company will begin pivotal Phase III trials of the Leutech radiological diagnostic kit for infection imaging in September. The trial protocol to apply Leutech to the diagnosis of equivocal appendicitis was discussed with FDA on July 23. The trials may be completed by the first calendar quarter of 1999, the company says